Stable small-molecule synthesis.
Neolix Pharma accelerates the transition from complex molecular research to stable, market-ready therapeutic products. From our state-of-the-art Bangalore hub, we develop, license, and supply advanced drug formulations to global distributors and healthcare networks.
Rigorous stability testing
Every formulation undergoes extensive stress-testing to ensure molecular stability before clinical batching. We deliver complete regulatory dossiers alongside every formulation license, ensuring transparent compliance tracking for international licensing partners.
Request formulation dossiers
Submit your licensing inquiry directly to our Bangalore operations team. Our technical officers will provide comprehensive formulation stability data sheets and regulatory dossiers within twenty-four hours to accelerate your procurement process.
Our physical operations in Bangalore North are open for rigorous distributor audits.
We maintain complete transparency in our formulation stability protocols and regulatory compliance tracking. International licensing partners are invited to visit our Bangalore North facility and audit our sterile synthesis infrastructure first-hand.